News from sangamo biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 05, 2014, 16:02 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At The 2014 Wedbush Securities Life Sciences Management Access Conference

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president of research and...

Aug 05, 2014, 08:30 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that five members of the Company's research and development team were recently named among...

Jul 23, 2014, 16:02 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Reports Second Quarter 2014 Financial Results

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its second quarter 2014 financial results and accomplishments. For the second...

Jul 16, 2014, 16:02 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Second Quarter 2014 Conference Call And Webcast

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its second quarter 2014 financial results after the...

Jun 19, 2014, 07:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Appoints H. Stewart Parker to its Board of Directors

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the appointment of H. Stewart Parker to the Company's Board of Directors. Ms. Parker, who...

Jun 17, 2014, 16:05 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference

 Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO,...

May 30, 2014, 07:05 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences And City of Hope Granted Strategic Partnership Award From California Institute for Regenerative Medicine To Support Clinical Trial Of Stem-Cell Based ZFP Therapeutic® For HIV/AIDS

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million...

May 29, 2014, 18:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At The Jefferies 2014 Global Healthcare Conference

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress...

May 28, 2014, 13:34 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Publication of Preclinical Data Demonstrating Gene Correction in SCID-X1 Human Hematopoietic Stem Cells

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication in Nature of data demonstrating efficient zinc finger nuclease...

May 27, 2014, 07:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Provides Clinical Update on SB-728-T Program and Progress in Other ZFP Applications at Annual Meeting of the American Society of Gene and Cell Therapy

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that data from clinical, preclinical and research-stage programs focused on the...

May 15, 2014, 16:05 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At The UBS Global Healthcare Conference

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president, research and...

May 14, 2014, 08:00 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences and Collaborators to Present Data on ZFP Therapeutic Applications and Developments at Annual Meeting of the American Society of Gene and Cell Therapy

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the...

May 06, 2014, 16:02 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Reports First Quarter 2014 Financial Results

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported first quarter 2014 financial results and accomplishments. For the first quarter...

May 01, 2014, 16:05 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress...

Apr 29, 2014, 16:05 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces First Quarter 2014 Conference Call And Webcast

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its first quarter 2014 financial results on Tuesday,...

Mar 20, 2014, 19:52 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of an underwritten public offering of common stock consisting of...

Mar 19, 2014, 16:01 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Public Offering Of Common Stock

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that it has commenced a $100 million underwritten public offering of shares of its common...

Mar 06, 2014, 12:16 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo Presents Clinical Data At CROI 2014 Demonstrating Enhancement Of SB-728-T Engraftment - Continued Control Of HIV Viral Load For 31 Weeks Without ART In SB-728-T Treated Subject

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the presentation of data from its SB-728-T program to develop a 'functional cure'...

Mar 05, 2014, 17:01 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

First-In-Man Study Of Genome Editing Using Sangamo's ZFN Technology Published In New England Journal Of Medicine

 Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication in the New England Journal of Medicine of the first clinical study of...

Feb 26, 2014, 16:45 ET
Sangamo BioSciences, Inc.  (PRNewsFoto/Sangamo BioSciences, Inc.)

Sangamo BioSciences Announces Presentation At The 2014 Cowen And Company Health Care Conference

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress...